Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (4458)	6/4/1998 9:58:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

You said: more so than the first time, when Asensio first attacked it... Did Ascensio do something this time? I've been so tied up I might have missed it. By the way, I liked your explanation about the disappointing test results on Vasomax. 12% better than placebo isn't much. And your comment that if the dosage doesn't influence efficacy then the drug is most likely not good... that's interesting. Is there anything in the literature to which you can point to support that? Linda